BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8785973)

  • 1. Development of an enzyme-linked immunosorbent assay for potency testing of erysipelas bacterins.
    Henderson LM; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():333. PubMed ID: 8785973
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
    Henderson LM; Jenkins PS; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 4. General information about the validation of serological method (ELISA) for the batch potency testing erysipelas vaccines.
    Altern Lab Anim; 2002; 30(5):486-7. PubMed ID: 12434771
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of an in vitro assay for measuring the relative potency of leptospiral bacterins containing serovar canicola and its correlation to the hamster potency assay.
    Ruby KW; Walden DM; Wannemuehler MJ
    Dev Biol Stand; 1996; 86():341. PubMed ID: 8785981
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross protection in mice and swine immunized with live erysipelas vaccine to challenge exposure with strains of Erysipelothrix rhusiopathiae of various serotypes.
    Takahashi T; Takagi M; Sawada T; Seto K
    Am J Vet Res; 1984 Oct; 45(10):2115-8. PubMed ID: 6497110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Identification of Virulence Genes in
    Shimoji Y; Ogawa Y; Tsukio M; Shiraiwa K; Nishikawa S; Eguchi M
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of a live attenuated Erysipelothrix rhusiopathiae vaccine for swine.
    Neumann EJ; Grinberg A; Bonistalli KN; Mack HJ; Lehrbach PR; Gibson N
    Vet Microbiol; 2009 Mar; 135(3-4):297-303. PubMed ID: 18977618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Leptospira pomona ELISA and its correlation with the hamster potency assay.
    Ruby KW
    Dev Biol Stand; 1996; 86():340. PubMed ID: 8785980
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross protection against Erysipelothrix rhusiopathiae serotype 10 induced by a serotype 1 and 2 vaccine.
    Redhead K; Pugh CA; Jensen NE; Houghton SB
    Vet Rec; 1998 May; 142(22):612. PubMed ID: 9682422
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of erysipelas vaccines.
    Ose EE
    J Am Vet Med Assoc; 1972 Feb; 160(4):603-6. PubMed ID: 5030609
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of an enzyme-linked immunosorbent assay for the serological detection of exposure of poultry in New Zealand to Erysipelothrix rhusiopathiae and their serological response to vaccination.
    Kurian A; Neumann EJ; Hall WF; Christensen N
    N Z Vet J; 2012 Mar; 60(2):100-5. PubMed ID: 22352927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antibiotics on the immune system of animals. II. Mouse experiments with an inactivated adsorbed vaccine against swine erysipelas.
    Tu TD
    Acta Vet Acad Sci Hung; 1981; 28(3):309-16. PubMed ID: 7258019
    [No Abstract]   [Full Text] [Related]  

  • 14. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
    Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antibiotics on the immune system of animals. I. Mouse experiments with the low-virulence VR2 strain of Erysipelothrix rhusiopathiae.
    Tu TD
    Acta Vet Acad Sci Hung; 1981; 28(3):297-307. PubMed ID: 7258018
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine.
    Shimoji Y; Oishi E; Muneta Y; Nosaka H; Mori Y
    Vaccine; 2003 Jan; 21(5-6):532-7. PubMed ID: 12531653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross protection of mice and swine given live-organism vaccine against challenge exposure with strains of Erysipelothrix rhusiopathiae representing ten serovars.
    Sawada T; Takahashi T
    Am J Vet Res; 1987 Jan; 48(1):81-4. PubMed ID: 3826847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative effectiveness of vaccines against erysipelas].
    Koniaev MT; Shcherbinin VK
    Veterinariia; 1980 Mar; (3):33-4. PubMed ID: 7395054
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the protective antigen of Erysipelothrix rhusiopathiae in the enzyme-linked immunosorbent assay and latex agglutination.
    Sato H; Yamazaki Y; Tsuchiya K; Aoyama T; Akaba N; Suzuki T; Yokoyama A; Saito H; Maehara N
    Zentralbl Veterinarmed B; 1998 Sep; 45(7):407-20. PubMed ID: 9780828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antibiotics on the immune system of animals. III. Experiments in pgis immunized with live and inactivated swine erysipelas vaccines.
    Tu TD
    Acta Vet Acad Sci Hung; 1981; 28(3):317-31. PubMed ID: 7258020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.